Lotus Eye Hospital P/E Ratio
Lotus Eye Hospital (LOTUSEYE) P/E ratio is 350.97 (High), EPS (TTM) ₹0.36, current price ₹107.36 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see LOTUSEYE company profile.
Current P/E Ratio
350.97
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
350.97
Current Price
₹107.36
EPS (TTM)
₹0.36
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
54.92
Sector Median
38.64
Sector Rank
#11 of 47
Sector Percentile
23.4%
LOTUSEYE P/E Ratio — Valuation Signal & Historical Context
Lotus Eye Hospital P/E 350.97 — signal: Overvalued. Analyse Lotus Eye Hospital shareholding analysis to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 350.97, suggesting caution for new investments
- Trading at premium to sector average PE of 54.92
LOTUSEYE vs Healthcare Services Peers — P/E Ratio Comparison
Lotus Eye Hospital P/E 350.97 vs Healthcare Services average 54.92, median 38.64 — range 6.55–408.11.
Sector Average
54.92
Sector Median
38.64
Lowest P/E
6.55
Highest P/E
408.11
Companies
47
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.55 | ₹99 | Low |
| Nidan Labs & Healthcare | NIDAN | 10.35 | ₹20 | Low |
| Deccan Health Care | DECCAN | 12.18 | ₹27 | Low |
| Shanmuga Hospital | SHANMUGA | 13.39 | ₹56 | Low |
| Abate AS Industries | ABATEAS | 17.43 | ₹182 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.73 | ₹1,045 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 17.94 | ₹1,165 | Moderate |
| Medinova Diagnostic Serv… | MEDINOV | 20.28 | ₹44 | Moderate |
| Clinitech Laboratory | CTLLAB | 20.81 | ₹8 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 21.56 | ₹4,024 | Moderate |